DAM Chicago 2019

One of the most overlooked parts of DAM implementation is change management and adoption planning.  Failed adoption can ruin all the hard work and preparation you and your team dedicated to standing up the perfect DAM. In this exciting and informative session you will get specific examples, successes and pitfalls to adoption from Stephanie Taubin, Sr. Manager, Marketing Operations of Biogen – founded in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). They also focus on less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).